The Food and Drug Administration last night said that Moderna can add up to 50% more doses per vial of its COVID-19 vaccine. Moderna had been shipping 10-dose vials; the FDA’s change will enable shipments to contain up to 15 doses per vial. 

In doing so, FDA also will permit vaccinators to extract an eleventh dose from existing 10-dose vials. 

Such a change is contingent on the availability of certain syringes and needles. Read the FDA’s updated provider fact sheet for more details.

Meanwhile, the Centers for Disease Control and Prevention today loosened federal guidance on travel during the COVID-19 pandemic, stating that fully vaccinated individuals can resume domestic and international travel. 

CDC recommends these individuals continue to wear masks in public but domestic travelers do not need to get tested for COVID-19 before and after travel, nor do they need to self-quarantine afterwards. International travelers should have a negative COVID-19 test within 3 to 5 days upon return.
 

Related News Articles

Headline
The Centers for Disease Control and Prevention Dec. 11 released a report that found last year’s version of the COVID-19 vaccine was 76% effective in preventing…
Headline
The AHA provided recommendations to the Food and Drug Administration Dec. 1 in response to a request for information on the measurement and evaluation of…
Headline
The Food and Drug Administration has identified a Class I recall of Baxter Life2000 Ventilation Systems due to a cybersecurity issue discovered through…
Headline
The Food and Drug Administration yesterday published an announcement from Otsuka ICU Medical saying that the company issued a voluntary recall for a mislabeled…
Headline
The Centers for Disease Control and Prevention will update its immunization schedules for the COVID-19 and chickenpox vaccines to adopt recent recommendations…
Headline
The Food and Drug Administration today issued a request for public comment on a series of questions regarding current approaches to evaluating artificial…